サルコペニア治療の世界市場レポート 2024年

サルコペニア治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.0％で44億4,000万米ドルに成長します。予測期間中に予想される成長は、個別化医療の採用、栄養介入の進歩、デジタルヘルスプラットフォームの統合、患者教育とエンパワーメントに焦点を当てた取り組み、世界ヘルスへの取り組みなど、さまざまな要因によってもたらされます。この期間に予想される主な動向には、個別化治療の台頭、新規薬剤クラスの出現、デジタルヘルスソリューションの統合、共同研究イニシアティブ、研究開発への継続的投資などが含まれます。

栄養失調の増加が予想され、今後のサルコペニア治療市場の成長を牽引するとみられます。栄養不良は、個人のエネルギーや栄養素の摂取不足、過剰、不均衡を含み、低栄養や過体重、肥満、食事に関連する非感染性疾患を含みます。サルコペニア治療は、筋肉量、筋力、および全体的な栄養状態を高めることを目的とした栄養療法や運動などの介入を通じて、高齢者の栄養不良とサルコペニアの同時発生状態に対処する上で重要な役割を果たしています。例えば、世界保健機関（WHO）が2023年12月に発表した報告書では、栄養不良が世界の健康上の重大な課題であると強調されており、2022年には推定4億6,200万人の低体重者と1億4,900万人の5歳未満児が発育阻害を経験しています。その結果、栄養失調の急増がサルコペニア治療市場成長の原動力となっています。

サルコペニア治療市場の主要企業は、治療の選択肢を増やすため、複数の先進的な臨床研究の開発に力を注いでいます。臨床試験は、医療介入の安全性、有効性、および/または結果を評価するために、ヒトを対象として実施される体系的な調査を含みます。例えば、2023年9月、フランスを拠点とするバイオテクノロジー企業Biophytis社は、サルコペニアを対象としたSARA-31フェーズ3試験を開始するための食品医薬品局（FDA）からの認可を公表しました。本試験は、サルコネオス（BIO101）の運動機能障害のリスクを有するサルコペニア患者に対する有効性と安全性を評価することを目的としています。本試験は、サルコネオスの技術的・薬学的治療法における重要な進歩を示すものであり、重症サルコペニア患者に対する有効性と安全性の点で有益な可能性を提供するものです。注目すべきは、FDAの承認を受けたサルコペニアを対象とした初めての第3相試験であるということです。本試験は、サルコペニア、歩行速度低下、握力低下を有する65歳以上の患者約900人を対象とします。主要評価項目は、大移動障害（MMD）リスク、歩行速度、握力、患者報告によるQOLの評価です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のサルコペニア治療市場、治療タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• プロテインサプリメント
• ビタミンB12サプリメント
• ビタミンDとカルシウムのサプリメント
• その他の治療タイプ
• 世界のサルコペニア治療市場、タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 原発性サルコペニア
• 二次性サルコペニア
• 世界のサルコペニア治療市場、投与経路別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 経口
• 非経口
• 経腸
• 世界のサルコペニア治療市場、流通チャネル別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル

第7章 地域別・国別分析

• 世界のサルコペニア治療市場、地域別、実績および予測、2018～2023年、2023～2028年、2033年
• 世界のサルコペニア治療市場、国別、実績および予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• サルコペニア治療市場の競合情勢
• サルコペニア治療市場企業プロファイル
  • Pfizer Inc.
  • F-Hoffmann La-Roche
  • Merck Sharp &Dohme Corp.（Merck &Co.）
  • AbbVie Inc.
  • Bayer AG

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi SA
• Abbott Laboratories Inc.
• GlaxoSmithKline plc
• Eli Lilly and Company
• BASF SE
• Nestle Health Science
• Haleon Group of Companies
• Regeneron Pharmaceuticals Inc.
• DSM
• American Way（Amway）Corporation
• Perrigo Company PLC
• Intas Pharmaceuticals Ltd
• Zydus Lifesciences
• Fermenta Biotech Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的分析

第36章 付録

Sarcopenia treatment encompasses medical interventions and lifestyle strategies tailored to counteract age-related muscle loss, aiming to preserve or enhance skeletal muscle mass and function. The goal of treatment is to mitigate age-related muscle decline, bolster muscle strength, and improve overall physical function and mobility.

The main types of sarcopenia treatments include protein supplements, vitamin B12 supplements, vitamin D and calcium supplements, and others. Protein supplements, available in forms such as bars, powders, or shakes derived from whey, plant, or meat sources, are utilized for both primary and secondary sarcopenia treatment and can be administered orally, parenterally, or enterally. These supplements are distributed through various channels including hospital pharmacies, retail pharmacies, and online pharmacies.

The sarcopenia treatment market research report is one of a series of new reports from The Business Research Company that provides sarcopenia treatment market statistics, including sarcopenia treatment industry global market size, regional shares, competitors with a sarcopenia treatment market share, detailed sarcopenia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sarcopenia treatment industry. This sarcopenia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sarcopenia treatment market size has grown strongly in recent years. It will grow from $3.30 billion in 2023 to $3.52 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth observed during the historical period can be attributed to several factors, including the aging population, increased awareness and diagnosis of medical conditions, lifestyle changes leading to health concerns, public health initiatives aimed at prevention and treatment, and regulatory approvals facilitating the availability of healthcare products and services.

The sarcopenia treatment market size is expected to see strong growth in the next few years. It will grow to $4.44 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The anticipated growth in the forecast period is driven by various factors, including the adoption of personalized medicine, advancements in nutritional interventions, the integration of digital health platforms, initiatives focused on patient education and empowerment, and global health efforts. Major trends expected during this period include the rise of personalized therapies, the emergence of novel drug classes, the integration of digital health solutions, collaborative research initiatives, and continued investment in research and development.

The anticipated increase in malnutrition is poised to drive the growth of the sarcopenia treatment market in the future. Malnutrition encompasses deficiencies, excesses, or imbalances in an individual's intake of energy and nutrients, including both undernutrition and overweight, obesity, and diet-related noncommunicable diseases. Sarcopenia treatment plays a crucial role in addressing the concurrent conditions of malnutrition and sarcopenia in older adults through interventions such as nutritional therapy and exercise, with the aim of enhancing muscle mass, strength, and overall nutritional status. For instance, a report published by the World Health Organization (WHO) in December 2023 highlighted malnutrition as a significant global health challenge, with an estimated 462 million underweight individuals and 149 million children under 5 experiencing stunting in 2022. Consequently, the surge in malnutrition acts as a driving force behind the growth of the sarcopenia treatment market.

Major companies in the sarcopenia treatment market are intensifying their focus on developing multiple advanced clinical studies to enhance treatment options. A clinical study involves a systematic investigation conducted on human subjects to assess the safety, efficacy, and/or outcomes of a medical intervention. For instance, in September 2023, Biophytis, a France-based biotechnology company, disclosed the authorization from the Food and Drug Administration (FDA) to commence the SARA-31 Phase 3 study in sarcopenia. This study aims to assess the efficacy and safety of Sarconeos (BIO101) in treating sarcopenic patients at risk of motor disability. Representing a significant advancement in technological and pharmaceutical treatment modalities, this study offers potential benefits in terms of efficacy and safety for severe sarcopenic patients. Notably, it marks the first-ever Phase 3 study in sarcopenia to receive FDA authorization. The study will involve approximately 900 patients aged over 65 with sarcopenia, low walking speed, and low hand grip strength. The primary endpoints will include the evaluation of the risk of major mobility disability (MMD), walking speed, hand grip strength, and patient-reported quality of life.

In October 2021, Rejuveron Life Sciences AG, a biotechnology company headquartered in Switzerland, completed the acquisition of Rejuvenate Biomed NV for $16.99 million. This strategic move aims to expedite the clinical advancement of Rejuvenate's primary candidate, RJx-01, targeting both acute and chronic sarcopenia. Rejuvenate Biomed NV, based in Belgium, is a clinical-stage company committed to the exploration and creation of therapies aimed at postponing the onset of age-related illnesses, including sarcopenia.

Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill

North America was the largest region in the sarcopenia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sarcopenia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sarcopenia treatment market consists of revenues earned by entities by providing nutritional therapy, combination therapy, and muscle strength. The market value includes the value of related goods sold by the service provider or included within the service offering. The sarcopenia market also includes sales of muscle stimulators, orthopedic braces and supports, joint replacement implants, anabolic agents, and more. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sarcopenia Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sarcopenia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sarcopenia treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sarcopenia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Treatment Type: Protein Supplements; Vitamin B12 Supplements; Vitamin D And Calcium Supplements; Other Treatment Types
• 2) By Type: Primary Sarcopenia; Secondary Sarcopenia
• 3) By Route Of Administration: Oral; Parenteral; Enteral
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Companies Mentioned: Pfizer Inc.; F-Hoffmann La-Roche; Merck Sharp & Dohme Corp. (Merck & Co.); AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sarcopenia Treatment Market Characteristics

3. Sarcopenia Treatment Market Trends And Strategies

4. Sarcopenia Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Sarcopenia Treatment Market Size and Growth

• 5.1. Global Sarcopenia Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Sarcopenia Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Sarcopenia Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sarcopenia Treatment Market Segmentation

• 6.1. Global Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Protein Supplements
• Vitamin B12 Supplements
• Vitamin D And Calcium Supplements
• Other Treatment Types
• 6.2. Global Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Primary Sarcopenia
• Secondary Sarcopenia
• 6.3. Global Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Enteral
• 6.4. Global Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels

7. Sarcopenia Treatment Market Regional And Country Analysis

• 7.1. Global Sarcopenia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Sarcopenia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sarcopenia Treatment Market

• 8.1. Asia-Pacific Sarcopenia Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sarcopenia Treatment Market

• 9.1. China Sarcopenia Treatment Market Overview
• 9.2. China Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sarcopenia Treatment Market

• 10.1. India Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sarcopenia Treatment Market

• 11.1. Japan Sarcopenia Treatment Market Overview
• 11.2. Japan Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sarcopenia Treatment Market

• 12.1. Australia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sarcopenia Treatment Market

• 13.1. Indonesia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sarcopenia Treatment Market

• 14.1. South Korea Sarcopenia Treatment Market Overview
• 14.2. South Korea Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sarcopenia Treatment Market

• 15.1. Western Europe Sarcopenia Treatment Market Overview
• 15.2. Western Europe Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sarcopenia Treatment Market

• 16.1. UK Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sarcopenia Treatment Market

• 17.1. Germany Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sarcopenia Treatment Market

• 18.1. France Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sarcopenia Treatment Market

• 19.1. Italy Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sarcopenia Treatment Market

• 20.1. Spain Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sarcopenia Treatment Market

• 21.1. Eastern Europe Sarcopenia Treatment Market Overview
• 21.2. Eastern Europe Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sarcopenia Treatment Market

• 22.1. Russia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sarcopenia Treatment Market

• 23.1. North America Sarcopenia Treatment Market Overview
• 23.2. North America Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sarcopenia Treatment Market

• 24.1. USA Sarcopenia Treatment Market Overview
• 24.2. USA Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sarcopenia Treatment Market

• 25.1. Canada Sarcopenia Treatment Market Overview
• 25.2. Canada Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sarcopenia Treatment Market

• 26.1. South America Sarcopenia Treatment Market Overview
• 26.2. South America Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sarcopenia Treatment Market

• 27.1. Brazil Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sarcopenia Treatment Market

• 28.1. Middle East Sarcopenia Treatment Market Overview
• 28.2. Middle East Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sarcopenia Treatment Market

• 29.1. Africa Sarcopenia Treatment Market Overview
• 29.2. Africa Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sarcopenia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Sarcopenia Treatment Market Competitive Landscape
• 30.2. Sarcopenia Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F-Hoffmann La-Roche
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck Sharp & Dohme Corp. (Merck & Co.)
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Sarcopenia Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. Abbott Laboratories Inc.
• 31.4. GlaxoSmithKline plc
• 31.5. Eli Lilly and Company
• 31.6. BASF SE
• 31.7. Nestle Health Science
• 31.8. Haleon Group of Companies
• 31.9. Regeneron Pharmaceuticals Inc.
• 31.10. DSM
• 31.11. American Way (Amway) Corporation
• 31.12. Perrigo Company PLC
• 31.13. Intas Pharmaceuticals Ltd
• 31.14. Zydus Lifesciences
• 31.15. Fermenta Biotech Limited

32. Global Sarcopenia Treatment Market Competitive Benchmarking

33. Global Sarcopenia Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sarcopenia Treatment Market

35. Sarcopenia Treatment Market Future Outlook and Potential Analysis

• 35.1 Sarcopenia Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Sarcopenia Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Sarcopenia Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer